Context Therapeutics Inc.
NASDAQ:CNTXBiotechnology
+$0.02 today
- Market cap
- $63.67M
- Beta
- 1.61
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$0.42
Volume 1.71M
Average 1.16M
Dividends
Context Therapeutics Inc. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
—
Shareholder Yield
0.00%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.
Competitor dividends
How does Context Therapeutics Inc. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Shattuck Labs, Inc. NASDAQ:STTK | $355.92M | 0.00% | $0.00 | 0.00% | 0.00% |
Ovid Therapeutics Inc. NASDAQ:OVID | $307.29M | 0.00% | $0.00 | 0.00% | 0.00% |
MacroGenics, Inc. NASDAQ:MGNX | $235.18M | 0.00% | $0.00 | 0.00% | 0.00% |
Whitehawk Therapeutics Inc NASDAQ:WHWK | $183.47M | 0.00% | $0.00 | 0.00% | 0.00% |
Oramed Pharmaceuticals Inc. NASDAQ:ORMP | $164.93M | 6.54% | $0.25 | 0.00% | 2.98% |
Connect Biopharma Holdings Limited NASDAQ:CNTB | $134.74M | 0.00% | $0.00 | 0.00% | 0.00% |
InflaRx N.V. NASDAQ:IFRX | $125.69M | 0.00% | $0.00 | 0.00% | 0.00% |
Kalaris Therapeutics Inc NASDAQ:KLRS | $69.76M | 0.00% | $0.00 | 0.00% | 0.00% |
ImageneBio Inc NASDAQ:IMA | $63.05M | 0.00% | $0.00 | 0.00% | 0.00% |
Clene Inc. NASDAQ:CLNN | $55.56M | 0.00% | $0.00 | 0.00% | 0.00% |
Questions
Dividend questions
Common questions about CNTX's dividend, answered from reported figures.
Does CNTX stock pay dividends?
Context Therapeutics Inc. (CNTX) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is CNTX's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.